#2017527
Eatocsasól
Etoxazole
Eatocsasól
Etoxazole
EATOCSASÓL
ETOXAZOLE
Eatocsasól
Etoxazole
Eatocsasól
Etoxazole
b) scriostar na colúin le haghaidh beansóáit dínádóiniam, dé-úróin agus eatocsasóil;
b) the columns for denatonium benzoate, diuron and etoxazole are deleted;
(2) in Iarscríbhinn V, cuirtear isteach na colúin seo a leanas le haghaidh beansóáit dínádóiniam, dé-úróin agus eatocsasóil:
(2) in Annex V, the following columns for denatonium benzoate, diuron and etoxazole are added:
Eatocsasól
Etoxazole
‘Eatocsasól
‘Etoxazole
Eatocsasól
Etoxazole
Eatocsasól (ISO) (CAS RN 153233-91-1) ag a bhfuil íonacht 94,8 % nó níos mó de réir meáchain
Etoxazole (ISO) (CAS RN 153233-91-1) of a purity by weight of 94,8 % or more
Eatocsasól (ISO) (CAS RN 153233-91-1) ag a bhfuil íonacht 94,8 % nó níos mó de réir meáchain
Etoxazole (ISO) (CAS RN 153233-91-1) of a purity by weight of 94,8 % or more
(1) I gcás beansóáit dínádóiniam, dé-úróin, eatocsasóil, meitimile agus teafluibeansúróin, leagadh síos uasleibhéil iarmhar (‘MRLanna’) in Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 396/2005.
(1) For denatonium benzoate, diuron, etoxazole, methomyl and teflubenzuron, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.
[4] EFSA Conclusion on the peer review of the pesticide risk assessment of the active substance etoxazole [Conclúid ón Údarás Eorpach um Shábháilteacht Bia maidir leis an athbhreithniú piaraí ar an measúnú riosca lotnaidicídí ar an tsubstaint ghníomhach eatocsasól]; EFSA Journal [Iris EFSA], 2017;15(10):4988.
[4] EFSA Conclusion on the peer review of the pesticide risk assessment of the active substance etoxazole; EFSA Journal 2017;15(10):4988.
Mar sin féin, ní dhearnadh an leithdháileadh sin go fóill maidir leis an meastóireacht ar an tsubstaint ghníomhach eatocsasól, ar substaint í a rachaidh a formheas in éag an 31 Eanáir 2028.
However, that allocation has not yet taken place for the evaluation of the active substance etoxazole, whose approval expires on 31 January 2028.
Eatocsasól (ISO) (CAS RN 153233-91-1) ag a bhfuil íonacht 94,8 % nó níos mó de réir meáchain
Etoxazole (ISO) (CAS RN 153233-91-1) of a purity by weight of 94,8 % or more
Rialachán Cur Chun Feidhme (AE) 2020/869 ón gCoimisiún an 24 Meitheamh lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beaflubútaimíd, beanalacsail, beintiavalacarb, défheineasáit, boscailid, brómocsainil, captan, ciasófaimíd, démheatomorf, eiteafón, eatocsasól, famocsadón, feanaimíofos, flumocsaisín, fluocsastróibin, foilpéad, foirmeiteanáit, meitríbhúisín, milbimeictin, tréithchineál 251 Paecilomyces lilacinus, feinmeideafam, foismeit, pirimeafos-meitil, própamacarb, próitiaconasól agus S-meitileaclór (IO L 201, 25.6.2020, lch. 7).
Commission Implementing Regulation (EU) 2020/869 of 24 June 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (OJ L 201, 25.6.2020, p. 7).
Rialachán Cur Chun Feidhme (AE) 2020/869 ón gCoimisiún an 24 Meitheamh 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beaflubútaimíd, beanalacsail, beintiavalacarb, défheineasáit, boscailid, brómocsainil, captan, ciasófaimíd, démheatomorf, eiteafón, eatocsasól, famocsadón, feanaimíofos, flumocsaisín, fluocsastróibin, foilpéad, foirmeiteanáit, meitríbhúisín, milbimeictin, tréithchineál 251 Paecilomyces lilacinus, feinmeideafam, foismeit, pirimeafos-meitil, própamacarb, próitiaconasól agus S-meitileaclór (IO L 201, 25.6.2020, lch. 7).
Commission Implementing Regulation (EU) 2020/869 of 24 June 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor (OJ L 201, 25.6.2020, p. 7).
Rialachán (AE) 441/2012 ón gCoimisiún an 24 Bealtaine 2012 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh défheineasáite, défheintrine, boscailide, cadúsafos, clórantrainileapróil, clóratailinile, clóitiainídine, ciopróconasóil, deiltemheitrine, díceamba, défeanaconasóil, déineacap, eatocsasóil, feinpiorocsamáite, fluibeindé-aimíde, fluidhé-ocsainile, gliofosáite, meatalacsaile-M, meiptildéineacap, nóvalúrón, tiaimeatocsam agus trí-asafos i dtáirgí áirithe nó ar tháirgí áirithe (IO L 135, 25.5.2012, lch. 4).
Commission Regulation (EU) No 441/2012 of 24 May 2012 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, bifenthrin, boscalid, cadusafos, chlorantraniliprole, chlorothalonil, clothianidin, cyproconazole, deltamethrin, dicamba, difenoconazole, dinocap, etoxazole, fenpyroximate, flubendiamide, fludioxonil, glyphosate, metalaxyl-M, meptyldinocap, novaluron, thiamethoxam, and triazophos in or on certain products (OJ L 135, 25.5.2012, p. 4).
lena leasaítear Iarscríbhinní II agus V a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh beansóáit dínádóiniam, dé-úróin, eatocsasóil, meitimile, agus teafluibeansúróin i dtáirgí áirithe nó ar tháirgí áirithe
amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for denatonium benzoate, diuron, etoxazole, methomyl and teflubenzuron in or on certain products
(4) Rinneadh formheas na substainte gníomhaí eatocsasól a athnuachan le Rialachán Cur Chun Feidhme (AE) 2020/2105 ón gCoimisiún le foráil shonrach nach n-údaróidh na Ballstáit ach úsáidí táirgí cosanta plandaí ar phlandaí ornáideacha i dtithe gloine buana.
(4) The approval of the active substance etoxazole was renewed by Commission Implementing Regulation (EU) 2020/2105 with a specific provision that only uses of plant protection products on ornamental plants in permanent greenhouses shall be authorised by Member States.
I gcomhthéacs an nós imeachta maidir le formheas na substainte gníomhaí sin, d’fhoilsigh an tÚdarás Eorpach um Shábháilteacht Bia (‘an tÚdarás’) conclúid maidir leis an athbhreithniú piaraí inar míníodh nach bhféadfaí rioscaí do shláinte an duine ó thomhaltas barraí inite arna gcóireáil le heatocsasól a chur san áireamh.
In the context of the procedure for the renewal of approval of that active substance, the European Food Safety Authority (‘the Authority’) published a conclusion on the peer review explaining that, due to insufficient data, risks for human health from consumption of edible crops treated with etoxazole could not be excluded.
Ba cheart na MRLanna le haghaidh eatocsasóil ar gach táirge a leagan síos ag na LODanna a bhaineann go sonrach leis an táirge in Iarscríbhinn V a ghabhann le Rialachán (CE) Uimh. 396/2005 i gcomhréir le hAirteagal 18(1), pointe (b) den Rialachán sin.
MRLs for etoxazole on all products should be set at the product specific LODs in Annex V to Regulation (EC) No 396/2005 in accordance with Article 18(1), point (b), of that Regulation.
[3] Rialachán Cur Chun Feidhme (AE) 2020/2105 ón gCoimisiún an 15 Nollaig 2020 maidir le hathnuachan ar fhormheas na substainte gníomhaí eatocsasól, mar shubstaint atá le hionadú, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún (IO L 425, 16.12.2020, lch. 96).
[3] Commission Implementing Regulation (EU) 2020/2105 of 15 December 2020 renewing the approval of the active substance etoxazole as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 425, 16.12.2020, p. 96).
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 686/2012 a mhéid a bhaineann le leithdháileadh ar Bhallstáit, chun críocha an nós imeachta athnuachana, na meastóireachta ar eatocsasól, ar substaint í a rachaidh a formheas in éag an 31 Eanáir 2028
amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028
Rialachán Cur Chun Feidhme (AE) 2020/869 ón gCoimisiún an 24 Meitheamh 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beaflubútaimíd, beanalacsail, beintiavalacarb, défheineasáit, boscailid, brómocsainil, captan, ciasófaimíd, démheatomorf, eiteafón, eatocsasól, famocsadón, feanaimíofos, flumocsaisín, fluocsastróibin, foilpéad, foirmeiteanáit, meitríbhúisín, milbimeictin, Paecilomyces lilacinus tréithchineál 251, feinmeideafam, foismeit, pirimeafos-meitil, própamacarb, próitiaconasól agus S-meitileaclór, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/869 of 24 June 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor is to be incorporated into the EEA Agreement.
Rialachán Cur Chun Feidhme (AE) 2020/2105 ón gCoimisiún an 15 Nollaig 2020 lena ndéantar formheas na substainte gníomhaí eatocsasól a athnuachan, mar shubstaint atá le hionadú, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/2105 of 15 December 2020 renewing the approval of the active substance etoxazole as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 is to be incorporated into the EEA Agreement.
32020 R 2105: Rialachán Cur Chun Feidhme (AE) 2020/2105 ón gCoimisiún an 15 Nollaig 2020 lena ndéantar formheas na substainte gníomhaí eatocsasól, mar shubstaint atá le hionadú, a athnuachan i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún. (IO L 425, 16.12.2020, lch. 96).
32020 R 2105: Commission Implementing Regulation (EU) 2020/2105 of 15 December 2020 renewing the approval of the active substance etoxazole as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 425, 16.12.2020, p. 96).